SEC Form 4 · accession 0001609351-16-000041
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph La Barge
Officer — See remarks
Period of report
May 19, 2016
Accepted (ET)
May 23, 2016 · 6:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 19, 2016 | M | 7,500 | $3.45 | A | 12,825 | D | |
| Common Stock | May 19, 2016 | S | 7,500 | $46.87 | D | 5,325 | D | |
| Common Stock | May 20, 2016 | M | 2,500 | $3.45 | A | 7,825 | D | |
| Common Stock | May 20, 2016 | S | 2,500 | $50.00 | D | 5,325 | D | |
| Common Stock | holding | — | — | — | 200 | I | Held by Reporting Person's immediate family members |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $3.45 | May 19, 2016 | M | 7,500 | D | — | Jun 9, 2024 | Common Stock | 7,500 | 17,883 | D |
| Employee Stock Option (right to buy)F2 | $3.45 | May 20, 2016 | M | 2,500 | D | — | Jul 1, 2024 | Common Stock | 2,500 | 29,429 | D |
Explanation of responses
- F125% vested November 11, 2014 and the remainder vests in equal quarterly installments over the following three years.
- F225% vested May 24, 2015 and the remainder vests in equal quarterly installments over the following three years.
Remarks
General Counsel and Head of Business Administration